Skip to main content
. 2016 Dec 26;2016:7147039. doi: 10.1155/2016/7147039

Figure 9.

Figure 9

Validated drugs. Candidate drugs with successful results for both the biological validation and computational evaluation are considered repositioned drugs for breast cancer.